Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 28 May 2021
Date:
28/05/2021
Location:
Virtual meeting
This extraordinary meeting is organised in the context of the evaluation of an application to extend the use of Comirnaty, a vaccine for COVID-19, to include children aged 12 to 15.
The aim of the meeting is to conclude the evaluation, if possible.
The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.